Risk of cancers proximal to the colon in fecal immunochemical test positive screenees in a colorectal cancer screening program
Gastro Journal | Gastroenterology
by W. de Klaver, M. van der Vlugt, M.C.W. Spaander, P.M. Bossuyt, E. Dekker
2d ago
In more than half of the colorectal cancer (CRC) screening participants with a positive fecal immunochemical test (FIT) result, no advanced neoplasia (AN) is detected at colonoscopy. The positive FIT result could also be generated by cancers located proximal to the colon: upper gastrointestinal, oral cavity, nose and throat cancers. We evaluated screenees’ risk of being diagnosed with a cancer proximal to the colon within the three years and compared risks between those with a positive versus those with a negative FIT ..read more
Visit website
Empowering Tomorrow’s Gastroenterologists and Their Patients:Integrating Motivational Interviewing into Fellowship Training
Gastro Journal | Gastroenterology
by Media N. Ismael, Lisa J. Merlo
1w ago
..read more
Visit website
“The OCEAN Study: Has Octreotide Quenched the Thirst for Angiodysplasia-Related Bleed?”
Gastro Journal | Gastroenterology
by Avinash Tiwari
1w ago
..read more
Visit website
Fecal microbiota transplantation for recurrent C. difficile infection can be the best therapeutic option in severely immunocompromised patients depending on a case-by-case assessment of the benefit/risk ratio
Gastro Journal | Gastroenterology
by Nicolas BENECH, Nadim CASSIR, Tatiana GALPERINE, Laurent ALRIC, Julien SCANZI, Harry SOKOL, French Fecal Transplant Group (GFTF)
1w ago
..read more
Visit website
Basket, Umbrella, and Platform Trials: The Potential for Master Protocol -Based Trials in Inflammatory Bowel Disease
Gastro Journal | Gastroenterology
by Sailish Honap, Bruce E. Sands, Vipul Jairath, Silvio Danese, Eric Vicaut, Laurent Peyrin-Biroulet
1w ago
..read more
Visit website
Measuring post-colonoscopy colorectal cancers: Variations in methodology to address indicator timeliness and use in high-risk populations
Gastro Journal | Gastroenterology
by Jill Tinmouth, Branson Chen, Yue Niu, Kyle Silveira, Linda Rabeneck, Catherine Dubé, Cancer Control and Evidence Integration PCCRC Method Working Group, Ontario Health, Cancer Control
1w ago
..read more
Visit website
Real-world Stool-based mSDC2 Test Improved Detection of Advanced Colorectal Neoplasia for Colorectal Cancer Screening: A Prospective, Multicenter, Community-based Study.
Gastro Journal | Gastroenterology
by Shengbing Zhao, Zixuan He, Xiangyu Sui, Song Zhang, Zhaoshen Li, Yu Bai, Community-based CRC Screening Study Group
1w ago
..read more
Visit website
New insights on genes, gluten and immunopathogenesis of celiac disease
Gastro Journal | Gastroenterology
by Valérie Abadie, Arnold Han, Bana Jabri, Ludvig M. Sollid
1w ago
Celiac disease (CeD) is a gluten-induced enteropathy that develops in genetically susceptible individuals on consumption of cereal gluten proteins. It is a unique complex immune disorder to study as the driving antigen is known and the tissue targeted by the immune reaction can be interrogated. This review integrates findings gained from genetic, biochemical and immunological studies, which together have revealed mechanisms of gluten peptide modification and HLA binding thereby enabling a maladapted anti-gluten immune response ..read more
Visit website
Past, present and future of non-invasive tests to assess gluten exposure, celiac disease activity, and end-organ damage
Gastro Journal | Gastroenterology
by Jocelyn A. Silvester, Luca Elli, Chaitan Khosla, Jason Tye-Din
1w ago
Although many biomarkers have been proposed and several are in widespread clinical use, there is no single readout or combination of readouts that correlates tightly with gluten exposure, disease activity or end-organ damage in treated celiac disease patients. Challenges to developing and evaluating better biomarkers include significant interindividual variability related to immune amplification of gluten exposure and how effects of immune activation are manifest. Furthermore, the current “gold standard” for assessment of end-organ damage, small intestinal biopsy, is itself highly imperfect, s ..read more
Visit website
The Economic Iceberg of Celiac Disease: More than the Cost of Gluten-Free Food
Gastro Journal | Gastroenterology
by Soran R. Bozorg, Anne Lee, Karl Mårild, Joseph Murray
1w ago
Celiac disease (CeD) is a chronic autoimmune disorder of global relevance, with the potential for acute and long-term complications. However, the economic burden of CeD is rarely considered and largely thought of as limited to the cost of gluten-free food. Fortunately, recent research has shed light on the various societal costs of CeD across the healthcare continuum.In this article, we summarize the current evidence on the economic impacts of CeD which suggest that the societal economic burden of CeD stretches beyond the cost of gluten-free food ..read more
Visit website

Follow Gastro Journal | Gastroenterology on FeedSpot

Continue with Google
Continue with Apple
OR